Ikena Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2024 | 3 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2024 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2024 | 2 | -$0.22 | -$0.20 | -$0.21 |
| Q1 2025 | 2 | -$0.22 | -$0.20 | -$0.21 |
| Q2 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2025 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q2 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q3 2026 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
Ikena Oncology, Inc. Earnings Date And Information
Ikena Oncology, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.08. The company had revenue of 0 for the quarter and had revenue of 9.16 M for the year. Ikena Oncology, Inc. has generated $-2 earnings per share over the last year ($-1.63 diluted earnings per share) and currently has a price-to-earnings ratio of -1.38. Ikena Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
Ikena Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.27 | -$0.21 | 0.06 | $1.25 M | $0 |
| 08/08/2024 | Q2 2024 | -$0.31 | -$0.28 | 0.03 | $875,000 | $0 |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.33 | 0.07 | $0 | |
| 03/12/2024 | Q4 2023 | -$0.41 | -$0.41 | 0 | $659,000 | |
| 11/09/2023 | Q3 2023 | -$0.44 | -$0.40 | 0.04 | $2.84 M | $1.19 M |
| 08/10/2023 | Q2 2023 | -$0.48 | -$0.44 | 0.04 | $3.85 M | $2.00 M |
| 05/15/2023 | Q1 2023 | -$0.46 | -$0.36 | 0.1 | $5.31 M | |
| 03/14/2023 | Q4 2022 | -$0.36 | $5.45 M | |||
| 11/07/2022 | Q3 2022 | -$0.50 | -$0.46 | 0.04 | $4.32 M | $6.40 M |
| 08/11/2022 | Q2 2022 | -$0.48 | -$0.55 | -0.07 | $3.87 M | $382,000 |
| 05/12/2022 | Q1 2022 | -$0.42 | -$0.46 | -0.04 | $3.38 M | |
| 03/17/2022 | Q4 2021 | $0.08 | $20.22 M | |||
| 11/10/2021 | Q3 2021 | -$0.41 | -$0.40 | 0.01 | $4.05 M | $3.75 M |
| 08/12/2021 | Q2 2021 | -$0.32 | -$0.35 | -0.03 | $3.93 M | $3.55 M |
| 05/13/2021 | Q1 2021 | -$0.68 | -$2.52 | -1.84 | $3.47 M | |
| 12/30/2020 | Q4 2020 | -$1.86 | $65,000 | |||
| 09/29/2020 | Q3 2020 | -$0.44 | $2.83 M | |||
| 06/29/2020 | Q2 2020 | -$0.36 | $3.07 M | |||
| 03/30/2020 | Q1 2020 | -$0.50 | $3.23 M | |||
| 12/30/2019 | Q4 2019 | -$1.93 | $2.80 M |
Ikena Oncology, Inc. Earnings: Frequently Asked Questions
-
When is Ikena Oncology, Inc.'s earnings date?
Ikena Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates.
-
Did Ikena Oncology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Ikena Oncology, Inc. (:IKNA) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.08.
-
How can I listen to Ikena Oncology, Inc.'s earnings conference call?
The conference call for Ikena Oncology, Inc.'s latest earnings report can be listened to online.
-
How can I read Ikena Oncology, Inc.'s conference call transcript?
The conference call transcript for Ikena Oncology, Inc.'s latest earnings report can be read online.
-
How much revenue does Ikena Oncology, Inc. generate each year?
Ikena Oncology, Inc. (:IKNA) has a recorded annual revenue of $9.16 M.
-
How much profit does Ikena Oncology, Inc. generate each year?
Ikena Oncology, Inc. (:IKNA) has a recorded net income of $9.16 M. Ikena Oncology, Inc. has generated $-1.63 earnings per share over the last four quarters.
-
What is Ikena Oncology, Inc.'s price-to-earnings ratio?
Ikena Oncology, Inc. (:IKNA) has a price-to-earnings ratio of -1.38 and price/earnings-to-growth ratio is -0.1.
